BCL2L1 and prostate cancer: Moreover, inhibiting the expression level of Bcl-xL were suggested to reverse radio-resistance and regulate radiation-induced apoptosis of mesothelioma, breast cancer, prostate cancer, colorectal cancer as well as non-small cell lung cancer [84, 87, 132, 133].